RT Book, Section
A1 Nurkin, Steven
A1 Tuttle, Rebecca
A2 Morita, Shane Y.
A2 Balch, Charles M.
A2 Klimberg, V. Suzanne
A2 Pawlik, Timothy M.
A2 Posner, Mitchell C.
A2 Tanabe, Kenneth K.
SR Print(0)
ID 1145761334
T1 Palliation of Incurable Esophageal Cancer
T2 Textbook of Complex General Surgical Oncology
YR 2018
FD 2018
PB McGraw-Hill Education
PP New York, NY
SN 9780071793315
LK accesssurgery.mhmedical.com/content.aspx?aid=1145761334
RD 2024/04/19
AB Generally,  cancer  of  the  esophagus  and  gastroesophageal  junction  carries  with  it  a  poor  prognosis.  The  expected  5-year  survival  with  esophageal  cancer  is  40%,  21%,  and  4%,  for  localized,  regional,  and  distant  disease,  respectively.1  Approximately  50%  of  patients  presenting  with  esophageal  cancer  are  not  candidates  for  surgical  resection  at  the  time  of  diagnosis.2  Unfortunately,  these  patients  frequently  have  symptoms,  particularly  dysphagia,  that  require  palliation.  Therefore,  the  first  objective  of  treatment  is  to  adequately  assess  their  symptoms.  Establishing  the  extent  of  dysphagia  (Table  91-1),  and  assessing  accompanying  pain,  bleeding,  aspiration,  and  other  symptoms  will  assist  in  determining  the  best  therapies  required  for  effective  palliation.